Publicacións (30) Publicacións de Carmen Mella Perez

2023

  1. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Clinical Features and Risk Factors for Mortality Among Long-term Care Facility Residents Hospitalized Due to COVID-19 in Spain

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 77, Núm. 4, pp. E138-E147

  2. Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 4, pp. 1115-1127

  3. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  4. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

  5. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534

  6. Impacto de las campañas de vacunación frente al meningococo en la incidencia de bacteriemia por Neisseria Meningitidis

    Galicia Clínica, Vol. 83, Núm. 2, pp. 70-70

  7. Impacto de las campañas de vacunación frente al neumococo en la incidencia de bacteriemia neumocócica y en la resistencia del neumococo a los antibióticos

    Galicia Clínica, Vol. 83, Núm. 2, pp. 61-61

  8. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734

  9. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

    Frontiers in Medicine, Vol. 9

  10. The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

    Journal of General Internal Medicine, Vol. 37, Núm. 1, pp. 168-175

  11. WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales

    Journal of General Internal Medicine, Vol. 37, Núm. 8, pp. 1980-1987

2021

  1. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  2. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

    PLoS ONE, Vol. 16, Núm. 2 February

  4. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

    Drugs, Vol. 81, Núm. 6, pp. 685-695

  5. Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs

    Thrombosis and Haemostasis, Vol. 121, Núm. 12, pp. 1650-1659

  6. Real-life impact of glucocorticoid treatment in covid-19 mortality: A multicenter retrospective study

    Journal of Clinical Medicine, Vol. 10, Núm. 20

2020

  1. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2

    International journal of chronic obstructive pulmonary disease, Vol. 15, pp. 3433-3445

  2. Covid 19 and venous thromboembolic disease. Review on a series of patients

    Galicia Clínica, Vol. 81, Núm. 3, pp. 66-69